BRAF and melanoma: Interestingly, the observation that a genetically induced reduction in TFEB level increased the antiproliferative effect exerted by a BRAF inhibitor suggests new possible therapeutic interventions targeting TFEB for managing melanoma and overcoming acquired resistance to standard therapies.